Search company, investor...

Founded Year

2014

Stage

Series E | Alive

Total Raised

$47.9M

Last Raised

$15.37M | 16 days ago

Revenue

$0000 

About Catalyst Orthoscience

Catalyst Orthoscience develops medical solutions that make orthopedic surgery less invasive for both surgeons and patients. Its shoulder replacement system helps to replace traditional shoulder implants which require the removal of the top of the humerus so a stem could be inserted down into the bone canal. The company was founded in 2014 and is based in Naples, Florida.

Headquarters Location

14710 Tamiami Trail N Suite 102

Naples, Florida, 34110,

United States

239-877-7237

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Catalyst Orthoscience Patents

Catalyst Orthoscience has filed 16 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/2/2020

2/7/2023

Orthopedic surgical procedures, Skeletal system, Muscles of the upper limb, Implants (medicine), Prosthetics

Grant

Application Date

4/2/2020

Grant Date

2/7/2023

Title

Related Topics

Orthopedic surgical procedures, Skeletal system, Muscles of the upper limb, Implants (medicine), Prosthetics

Status

Grant

Latest Catalyst Orthoscience News

Catalyst OrthoScience Announces Mark Quick as CFO

Jul 5, 2023

- Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed seasoned medical device leader Mark Quick as chief financial officer of the organization, effective immediately. Quick joins Catalyst with nearly two decades of medical device experience. He was most recently at Orthofix Medical Inc. where he served in financial leadership and business development roles of increasing responsibility across financial planning and analysis, investor relations, and mergers and acquisitions. Prior to Orthofix, he served as a sell-side equity research analyst covering the medical device industry at Canaccord Genuity. Quick holds a Bachelor of Science in Mechanical Engineering from the University of Massachusetts, Amherst and an International Master of Business Administration from the University of South Carolina. “I am thrilled to join Carl and the rest of the talented Catalyst team in their commitment, dedication, and focus to providing differentiated solutions to shoulder surgeons and patients,” said Quick. “With its growing product portfolio, Catalyst is positioned to accelerate expansion of its distribution channel leading to broad adoption in the high-growth $1.5 billion U.S. shoulder replacement market.” Catalyst recently received 510(k) clearance from the FDA to market its fully convertible stemmed total shoulder arthroplasty system with an ellipsoid anatomic head. This is the market’s first stemmed arthroplasty system featuring an ellipsoid humeral head, and expands the Catalyst portfolio to offer stemless, stemmed, and convertible shoulder replacement systems.

Catalyst Orthoscience Frequently Asked Questions (FAQ)

  • When was Catalyst Orthoscience founded?

    Catalyst Orthoscience was founded in 2014.

  • Where is Catalyst Orthoscience's headquarters?

    Catalyst Orthoscience's headquarters is located at 14710 Tamiami Trail N, Naples.

  • What is Catalyst Orthoscience's latest funding round?

    Catalyst Orthoscience's latest funding round is Series E.

  • How much did Catalyst Orthoscience raise?

    Catalyst Orthoscience raised a total of $47.9M.

  • Who are the investors of Catalyst Orthoscience?

    Investors of Catalyst Orthoscience include Mutual Capital Partners, Finistere Ventures, RC Capital, Paycheck Protection Program, TiE Tampa Bay Angel Fund and 3 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.